immunotherapy | International Myeloma Foundation

female scientist doing lab work

Week in Review

June 25

May and June 2026: What's New in Myeloma?

IMS 2025

Week in Review

December 4

Top Takeaways from the 2025 International Myeloma Society Annual Meeting

Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers the internet’s most trending search questions about immunotherapy and multiple myeloma.

Trending Searches in Myeloma

September 12

What is Immunotherapy for Multiple Myeloma? Understanding Its Role in Treatment

2024 IMWG Group Photo

Week in Review

June 20

The 15th Annual IMWG Summit: Charting a New Way Forward

Bispecific Antibody Targets Made Simple

Myeloma Made Simple

June 6

Myeloma Made Simple: Bispecific Antibody Targets Made Simple | Myeloma Targeting with Bispecifics

Myeloma Made Simple: Bispecific Antibodies Made Simple

Myeloma Made Simple

May 29

Myeloma Made Simple: Bispecific Antibodies Made Simple | Bispecific Antibodies for Myeloma Treatment

tardigrade

Week in Review

May 16

Why Resilience Really Matters for Myeloma Patients

2023 Top Research ASCO banner

June 22

Top Myeloma Research Presented at ASCO & EHA Webinar 2023

Bispecifics Part 2: Monoclonal and Bispecific Antibodies

Emerging Therapies

January 13

Bispecifics Part 2: Monoclonal and Bispecific Antibodies

Bispecifics Part 1: Immune System and Immunotherapy Basics

Emerging Therapies

January 13

Bispecifics Part I: Immune System and Immunotherapy Basics

Top myeloma research at ASCO

July 7

Top Myeloma Research Presented at ASCO & EHA Webinar

Masked researcher analyzes sample under lab microscope

Clinical Trials and Treatments

May 5

Bispecific Antibodies: The Next Wave of Immunotherapy in Myeloma is Coming

Subscribe to immunotherapy

Give Where Most Needed